Or-Geva N[au] - Search Results

Year	Number of Results
2011	1
2012	1
2013	2
2014	1
2015	3
2016	1
2017	2
2018	2
2019	2
2021	1
2023	0

1

The evolution of T-cell depletion in haploidentical stem-cell transplantation.

Or-Geva N, Reisner Y. Or-Geva N, et al. Br J Haematol. 2016 Mar;172(5):667-84. doi: 10.1111/bjh.13868. Epub 2015 Dec 18. Br J Haematol. 2016. PMID: 26684279 Review.

2

Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy.

Reisner Y, Or-Geva N. Reisner Y, et al. Among authors: or geva n. Semin Hematol. 2019 Jul;56(3):173-182. doi: 10.1053/j.seminhematol.2019.03.003. Epub 2019 Mar 27. Semin Hematol. 2019. PMID: 31202427 Review.

3

Megadose stem cell administration as a route to mixed chimerism.

Or-Geva N, Reisner Y. Or-Geva N, et al. Curr Opin Organ Transplant. 2014 Aug;19(4):334-41. doi: 10.1097/MOT.0000000000000095. Curr Opin Organ Transplant. 2014. PMID: 24905022 Review.

4

Metabolomic Characterization of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS).

Murgia F, Gagliano A, Tanca MG, Or-Geva N, Hendren A, Carucci S, Pintor M, Cera F, Cossu F, Sotgiu S, Atzori L, Zuddas A. Murgia F, et al. Among authors: or geva n. Front Neurosci. 2021 May 28;15:645267. doi: 10.3389/fnins.2021.645267. eCollection 2021. Front Neurosci. 2021. PMID: 34121984 Free PMC article.

5

Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance.

Or-Geva N, Reisner Y. Or-Geva N, et al. Regen Med. 2015;10(3):239-42. doi: 10.2217/rme.14.94. Regen Med. 2015. PMID: 25933232 No abstract available.

6

Next-generation CD8 memory veto T cells directed against memory antigens.

Or-Geva N, Gidron-Budovsky R, Sidlik-Muskatel R, Singh AK, Reisner Y. Or-Geva N, et al. Leukemia. 2019 Nov;33(11):2737-2741. doi: 10.1038/s41375-019-0501-1. Epub 2019 Jun 12. Leukemia. 2019. PMID: 31189891 No abstract available.

7

Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype.

Ophir E, Eidelstein Y, Bachar-Lustig E, Hagin D, Or-Geva N, Lask A, Reisner Y. Ophir E, et al. Among authors: or geva n. Best Pract Res Clin Haematol. 2011 Sep;24(3):393-401. doi: 10.1016/j.beha.2011.05.007. Epub 2011 Jul 13. Best Pract Res Clin Haematol. 2011. PMID: 21925092 Review.

8

Molecular signature of Epstein-Barr virus infection in MS brain lesions.

Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH. Moreno MA, et al. Among authors: or geva n. Neurol Neuroimmunol Neuroinflamm. 2018 Jun 7;5(4):e466. doi: 10.1212/NXI.0000000000000466. eCollection 2018 Jul. Neurol Neuroimmunol Neuroinflamm. 2018. PMID: 29892607 Free PMC article.

9

Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.

Aversa F, Bachar-Lustig E, Or-Geva N, Prezioso L, Bonomini S, Manfra I, Monti A, Schifano C, Zlotnikov-Klionsky Y, Martelli MF, Sammarelli G, Sassi M, Soli M, Giuliodori S, Benecchi M, Giuliani N, Lohr F, Pratissoli S, Reisner Y. Aversa F, et al. Among authors: or geva n. Blood Adv. 2017 Oct 30;1(24):2166-2175. doi: 10.1182/bloodadvances.2017009423. eCollection 2017 Nov 14. Blood Adv. 2017. PMID: 29296864 Free PMC article.

10

The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT.

Or-Geva N, Reisner Y. Or-Geva N, et al. Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S14-20. doi: 10.1038/bmt.2015.89. Bone Marrow Transplant. 2015. PMID: 26039201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results